Top Markets
Coin of the day
Shanghai Chicmax Cosmetic Co., Ltd. Shanghai Chicmax Cosmetic Co., Ltd.

Shanghai Chicmax Cosmetic Co., Ltd.

2145
Kedudukan dalam Saham #8879
Shanghai Chicmax Cosmetic Co., Ltd. is a multifaceted beauty corporation based... Shanghai Chicmax Cosmetic Co., Ltd. is a multifaceted beauty corporation based in China, specializing in the entire product lifecycle—from innovation and production to market distribution—for skincare, as well as maternity and infant care lines. The company provides an extensive array of cosmetic goods, including specialized serums, moisturizing lotions, hair cleansers, and facial treatments, alongside various other dermatological and trichological solutions. These offerings are presented through a broad spectrum of brands such as KANS, One Leaf, Baby Elephant, BIO-G, asnami, KYOCA, newpage, ARMIYO, and TAZU. Furthermore, the firm actively oversees its supply chain management operations. Established in 2003 and headquartered in Shanghai, People's Republic of China, the company underwent a rebranding in 2020, transitioning from its former identity as Shanghai Kaka Cosmetic Co., Ltd.
Harga Saham
$2.88
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.15B
Perubahan (1 hari)
-3.35%
Perubahan (1 tahun)
-75.15%
Negara
CN
Perdagangan Shanghai Chicmax Cosmetic Co., Ltd. (2145)
Hasil untuk Shanghai Chicmax Cosmetic Co., Ltd. (2145)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Shanghai Chicmax Cosmetic Co., Ltd., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Shanghai Chicmax Cosmetic Co., Ltd. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$87.03B -
US
$51.67B -
FR
$21.05B -
US
$7.28B -
IN
$15.05B -
US